A Case of Measles Initially Diagnosed as MIS-C in the COVID-19 Pandemics

Fever and rash are a common symptom combination in children. Etiological studies are carried out primarily for the most common diseases. For this reason, in the period of the new Coronavirus disease-2019 (COVID-19) pandemic, especially COVID-19-related multi-inflammatory syndrome (MIS-C) comes to mind in children with this combination. Measles infection was detected in an 18-month-old Syrian girl who was hospitalized with the diagnosis of fever, conjunctivitis, pneumonia, maculopapular rash during the COVID-19 pandemic period. The case died with pneumonia and septic shock. With this case, we wanted to emphasize that during the COVID-19 pandemic, and measles should also be considered in the differential diagnosis of MIS-C in cases with fever, maculopapular rash and conjunctivitis. © 2023 by Society of Pediatric Emergency and Intensive Care Medicine Journal of Pediatric Emergency and Pediatric Intensive Care published by Galenos Yayınevi.

The First Case of Multisystem Inflammatory Syndrome in Children Successfully Treated with Combined Therapies Including Extracorporeal Membrane Oxygenation and Plasmapheresis

Multisystem inflammatory syndrome in children (MIS-C) is a severe disease that can lead to death. There is no definitive treatment for MIS-C yet. It has been reported that intravenous immunoglobulin, intravenous methylprednisolone, fluid supplements, antibiotics, inotropics, extracorporeal membrane oxygenation (ECMO), plasmapheresis, biological therapy, and anticoagulation therapy can be used for treatment. In this article, we presented an 8-year-old girl child patient who survived due to timely administered ECMO and combined therapies including plasmapheresis without any sequela despite her life-threatening condition due to MIS-C.